405 filings
Page 4 of 21
6-K
m5yc81r
24 Aug 22
Galapagos to present at upcoming investor conferences
4:48pm
6-K
63zb q0pwt5pb0m
19 Aug 22
Galapagos receives transparency notification from FMR LLC
8:43am
6-K
te7bb t3quotgs
9 Aug 22
Galapagos receives transparency notification from FMR LLC
6:20am
6-K
41hut1 uo
8 Aug 22
First key steps in pipeline rebuild and strong commercial progress in H1 2022
4:59pm
6-K
cvn14p zpt
23 Jun 22
Galapagos to acquire CellPoint and AboundBio to accelerate access to next-generation cell therapies
11:21am
6-K
sdieu9 h60wc7y
23 Jun 22
Current report (foreign)
11:01am
6-K
un4rmq6 7c
2 Jun 22
Galapagos receives transparency notification from FMR LLC
6:00am
6-K
s8w xmgmu3ymf1c0qdn
31 May 22
Current report (foreign)
1:39pm
6-K
5uv2vb tx5ntv4pt8
11 May 22
Current report (foreign)
4:05pm
6-K
wu6evbzq
9 May 22
Galapagos creates new subscription right plans
11:54am
6-K
8c5ja
6 May 22
Current report (foreign)
5:18pm
6-K
vcfars9z
28 Apr 22
Current report (foreign)
4:06pm
6-K
0g264
27 Apr 22
Galapagos announces appointment of Dr. Paul Stoffels as Chairman of the board
6:00am
6-K
oiok0pd 21477b2upd8
11 Apr 22
Current report (foreign)
5:14pm
6-K
q3m7 x40z2
28 Mar 22
Jyseleca® approved in Japan for ulcerative colitis
1:50pm
6-K
v404oy2vmn67j
24 Mar 22
Galapagos publishes 2021 annual report and announces Biographies of proposed new board members
8:13pm
6-K
5wdqw49m 94g
24 Mar 22
Current report (foreign)
9:51am
6-K
y9x21k
24 Feb 22
Galapagos 2021 results set stage for future growth
5:19pm
6-K
fvso3g6
7 Feb 22
Galapagos receives transparency notification from EcoR1 Capital
2:40pm